Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2005
03/24/2005CA2537574A1 Stationary phases and a purification process using the stationary phases
03/24/2005CA2537429A1 Method and device for detecting feline immunodeficiency virus
03/24/2005CA2537250A1 Topical preparations comprising a hydrophilic carrier and a silicone matrix
03/24/2005CA2536746A1 Hydrophobic drug compositions containing reconstitution enhancer
03/24/2005CA2536735A1 Methods for determining cd8+ t-cell epitopes
03/24/2005CA2536396A1 Methods of using wisp antagonists
03/24/2005CA2535279A1 Compounds that modulate neuronal growth and their uses
03/24/2005CA2534442A1 Adipocyte complement related protein zacrp12
03/24/2005CA2531878A1 Therapeutic use of g53135-05(fgf-20) in radiation protection
03/24/2005CA2526720A1 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
03/24/2005CA2523607A1 Treatment of inflammatory respiratory diseases
03/23/2005EP1516932A1 Poxvirus with targeted infection specificity
03/23/2005EP1516881A2 Composition and method for modulating dendritic Cell-T cell interaction
03/23/2005EP1516629A2 Humanized anti CD-11a antibodies
03/23/2005EP1516628A1 Stable isotonic lyophilized protein formulation
03/23/2005EP1516627A1 Interferon-Gamma for the treatment of diseases associated with the NOD2 gene
03/23/2005EP1516626A1 A Teicoplanin composition with improved antibiotic activity
03/23/2005EP1516625A1 Uses of neuronal channels-forming pannexins for therapy and diagnosis in mammals
03/23/2005EP1516597A1 Drug eluting stent
03/23/2005EP1516190A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor
03/23/2005EP1516184A2 Cell penetrating peptides
03/23/2005EP1516179A1 Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders
03/23/2005EP1516064A2 Methods of using 46828, a human acyl-coa synthetase
03/23/2005EP1516063A2 Nucleotide and amino acid sequences relating to respiratory diseases and obesity
03/23/2005EP1516054A2 Fusion constructs containing active sections of tnf ligands
03/23/2005EP1516049A2 Compositions and methods for the therapy and diagnosis of lung cancer
03/23/2005EP1516047A1 Purified pkb ser 473 kinase and uses thereof
03/23/2005EP1516044A2 SOLUBLE GLcNAC PHOSPHOTRANSFERASE
03/23/2005EP1515991A2 Pain signaling molecules
03/23/2005EP1515990A2 Antagonists of cxcr3-binding cxc chemokines
03/23/2005EP1515989A1 Immunogenic conjugates
03/23/2005EP1515988A1 Dna sequence and recombinant production of the grass pollen allergen phl p4
03/23/2005EP1515985A2 Methods of screening molecular libraries for active molecules that restore the function of mutant p53
03/23/2005EP1515984A1 Peptide derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions
03/23/2005EP1515983A1 Antibacterial amide macrocycles
03/23/2005EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer
03/23/2005EP1515981A4 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
03/23/2005EP1515981A2 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515754A2 Beta-2-glycoprotein 1 is an inhibitor of angiogenesis
03/23/2005EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
03/23/2005EP1515752A1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
03/23/2005EP1515749A1 Combined use of a modulator of cd3 and a glp-1 compound
03/23/2005EP1515746A2 Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
03/23/2005EP1515745A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
03/23/2005EP1515744A2 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
03/23/2005EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
03/23/2005EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
03/23/2005EP1515741A1 Composition comprising viscous fibers and viscosity-lowering proteins
03/23/2005EP1515740A1 Aqueous preparation containing oligopeptides and etherified cyclodextrin
03/23/2005EP1515739A2 Methods for identifying compounds for regulating muscle mass or function using amylin receptors
03/23/2005EP1515738A2 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
03/23/2005EP1515735A1 Botulinum toxins for treating priapism
03/23/2005EP1515733A2 Method for preparing a solid-fibrin web
03/23/2005EP1515720A1 Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions
03/23/2005EP1515719A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
03/23/2005EP1515704A1 Microcapsules for the delayed, controlled release of perindopril
03/23/2005EP1407049A4 Histone deacetylase and methods of use thereof
03/23/2005EP1401871B1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells
03/23/2005EP1381392A4 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same
03/23/2005EP1357937B1 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology
03/23/2005EP1345618B1 Chlorzoxazone for the treatment of psoriasis
03/23/2005EP1343542B1 Carrier with solid fibrinogen and solid thrombin
03/23/2005EP1311285B1 Liquid pharmaceutical composition containing an erythropoietin derivative
03/23/2005EP1228373B1 Diagnosis and therapy of cancer using sgp28-related molecules
03/23/2005EP1198478B1 Somatostatin analogs and their use for the treatment of cancer
03/23/2005EP1185623A4 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
03/23/2005EP1181382B1 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
03/23/2005EP1114166B1 Method for down-regulating osteoprotegerin ligand activity
03/23/2005EP1104305B1 Use of angiotensin in the treatment of cancer metastasis
03/23/2005EP1068232B1 Human antibiotic protein
03/23/2005EP0939813B1 Breast carcinoma-associated gene
03/23/2005EP0937104B1 Endothelium specific expression regulated by epcr control elements
03/23/2005EP0845005B1 Traf inhibitors
03/23/2005EP0832241B1 Mutants of streptococcal toxin a and methods of use
03/23/2005EP0804613B1 Dap-2 tumor suppressor gene, protein encoded thereby and use of said gene and protein
03/23/2005EP0723398B1 Superoxide dismutase mimetics
03/23/2005EP0662092B1 Activity-dependent neurotrophic factor
03/23/2005EP0574579B1 Dna encoding a human 5-ht 1f receptor and uses thereof
03/23/2005CN1599867A Immunocytokines with modulated selectivity
03/23/2005CN1599797A Intact minicells as vectors for DNA transfer and gene therapy in vitro and in vivo
03/23/2005CN1599792A Nutrient medium for maintaining neural cells in injured nervous system
03/23/2005CN1599753A Gene regulatory peptides
03/23/2005CN1599752A Nucleic protein 'Shoca'-a component of wnt signal transmission channel
03/23/2005CN1599750A Cytotoxic protein and utilization thereof
03/23/2005CN1599749A Peptides promoting cell adherence, growth and secretion
03/23/2005CN1599748A Novel peptides and medicinal uses thereof
03/23/2005CN1599747A Isolation of lectins
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599720A Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr)
03/23/2005CN1599623A Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
03/23/2005CN1599622A Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
03/23/2005CN1599621A Use of collagenase to facilitate guide wire crossing in total arterial occlusions
03/23/2005CN1599620A Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod
03/23/2005CN1599619A Methods and compositions for treating dermal lesions
03/23/2005CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha
03/23/2005CN1599616A Storage-stable human fibrinogen solutions
03/23/2005CN1597965A Man's serum albumin with man's parathormone (1-34) fusion protein and its application
03/23/2005CN1597964A Expression and purification of M protein in recombined SARS coronary virus
1 ... 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 ... 3163